Exercise intervention decreases acute and late doxorubicin‐induced cardiotoxicity

BACKGROUND: Doxorubicin (Dox) is one of the most effective chemotherapy agents used to treat adolescent and young adult sarcoma patients. Unfortunately, Dox causes cardiotoxicities that compromise long‐term survival. We investigated whether exercise prevented cardiotoxicity and increased survival fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Chandra, Joya, Kleinerman, Eugenie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559466/
https://www.ncbi.nlm.nih.gov/pubmed/34523825
http://dx.doi.org/10.1002/cam4.4283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559466/
https://www.ncbi.nlm.nih.gov/pubmed/34523825
http://dx.doi.org/10.1002/cam4.4283

Ejemplares similares